⚠️ Critical Medical Considerations:

• Always consult with oncologist or primary care physician before starting
• Continue all conventional treatments - RSO is complementary, not replacement therapy
• Monitor for drug interactions, especially with chemotherapy agents
• Regular blood work and liver function tests recommended

• Ultra-Low Starting Dose: Begin with 0.025ml (half of standard starting dose)
• Slower Titration: Increase dose weekly rather than every 4 days
• Drug Interaction Monitoring: Careful assessment with multiple medications
• Fall Risk Assessment: Monitor for dizziness and balance issues
• Cognitive Monitoring: Regular assessment of mental clarity

Primary Effects: Anti-inflammatory, anxiolytic, anticonvulsant, neuroprotective

Mechanism: CB2 receptor modulation, 5-HT1A receptor agonism, TRPV1 activation

Clinical Applications: Epilepsy (FDA-approved), anxiety, inflammation, pain management

Research Status: Extensive clinical validation with FDA-approved medications (Epidiolex)

Primary Effects: Mild psychoactivity, appetite stimulation, antiemetic, anxiolytic

Mechanism: CB1 receptor partial agonist (lower binding affinity than Delta-9 THC)

Clinical Applications: Nausea control, appetite enhancement, anxiety with reduced psychoactivity

Research Status: Emerging research shows promise for reduced anxiety compared to Delta-9 THC⁷

Primary Effects: Anti-inflammatory, antibacterial, neuroprotective, potential anti-tumor

Mechanism: CB1/CB2 receptor interaction, α2-adrenoceptor agonism

Clinical Applications: IBD, glaucoma, neurodegenerative diseases, bacterial infections

Research Status: Preclinical studies show significant therapeutic potential⁶

Primary Effects: Non-psychoactive, anti-inflammatory, neuroprotective, antiemetic

Mechanism: TRPA1 channel activation, PPARγ agonism (non-CB receptor mediated)

Clinical Applications: Inflammation, nausea, neurodegenerative conditions

Decarboxylation: Converts to psychoactive Delta-9 THC when heated

Primary Effects: Sedative, sleep-promoting, mild psychoactivity

Mechanism: CB1 receptor weak agonist, enhanced by THC presence

Clinical Applications: Insomnia, sleep disorders, restlessness

Research Status: Studies confirm sedative effects, especially in combination with THC⁹

Primary Effects: Anti-inflammatory, neurogenesis promotion, mood enhancement

Mechanism: TRPA1 activation, anandamide reuptake inhibition

Clinical Applications: Depression, neurodegenerative diseases, inflammation

Research Status: Emerging evidence for neurogenesis and mood regulation¹⁰

Primary Effects: Psychoactive, analgesic, antiemetic, appetite stimulation

Mechanism: CB1 receptor full agonist, primary psychoactive compound

Clinical Applications: Pain, nausea, appetite loss, muscle spasticity

Legal Status: Controlled to maintain federal compliance while preserving efficacy

Medical History

• ☐ Complete medical history and current medications
• ☐ Previous cannabis use and tolerance
• ☐ Substance use disorder history
• ☐ Psychiatric history (especially psychosis, schizophrenia)
• ☐ Cardiovascular status assessment
• ☐ Liver and kidney function evaluation

Contraindication Screening

• ☐ Pregnancy/breastfeeding status
• ☐ Personal/family history of psychosis
• ☐ Severe cardiovascular disease
• ☐ Severe respiratory conditions
• ☐ Active substance use disorders
• ☐ Age considerations (pediatric/geriatric)

Drug Interaction Assessment

• ☐ Anticoagulants (warfarin, heparin)
• ☐ CNS depressants (benzodiazepines, opioids)
• ☐ Antiepileptic drugs (clobazam, valproate)
• ☐ Immunosuppressants (tacrolimus, cyclosporine)
• ☐ Chemotherapy agents
• ☐ Cardiac medications

Conservative Protocol (Recommended for Most Patients)

Intensive Protocol (For Severe Conditions, Medical Supervision Required)

Efficacy Monitoring

• Symptom Tracking: Validated scales (VAS for pain, GAD-7 for anxiety)
• Functional Assessment: Activities of daily living, quality of life measures
• Objective Measures: Sleep studies, inflammation markers, seizure frequency
• Patient-Reported Outcomes: Standardized questionnaires, daily logs

Safety Monitoring

• Vital Signs: Blood pressure, heart rate, respiratory rate
• Cognitive Assessment: Mental status exams, cognitive screening tools
• Laboratory Monitoring: Liver function, complete blood count
• Drug Levels: Therapeutic drug monitoring for interacting medications

Psychosocial Monitoring

• Mental Health Screening: Depression, anxiety, psychosis risk
• Substance Use Assessment: Cannabis use disorder screening
• Social Functioning: Work, relationships, daily activities
• Caregiver Assessment: Family impact, caregiver burden

CYP Enzyme Inhibition

• CBD inhibits CYP2C19: Increases clobazam levels, risk of toxicity
• THC/CBD inhibit CYP3A4: Elevated levels of tacrolimus, cyclosporine
• Combined with ketoconazole: Nearly doubles THC/CBD concentrations

CYP Enzyme Induction

• Regular cannabis use induces CYP1A2: Increases clearance of theophylline, olanzapine
• Reduced drug efficacy: May require dose adjustments for affected medications

Epidiolex (CBD): FDA-approved for Dravet syndrome and Lennox-Gastaut syndrome epilepsy

Marinol/Syndros (Dronabinol): FDA-approved for chemotherapy-induced nausea and AIDS-related anorexia

Cesamet (Nabilone): FDA-approved for chemotherapy-induced nausea and vomiting

Clinical Significance: These approvals establish cannabinoids as legitimate pharmaceutical agents with proven efficacy in specific conditions⁵.

Nausea and Vomiting: Multiple RCTs demonstrate cannabinoid efficacy for chemotherapy-induced symptoms

Pain Management: Moderate evidence for cancer-related pain relief

Appetite Stimulation: Well-documented THC effects on appetite and weight gain

Quality of Life: Improvements in sleep, mood, and overall well-being reported in cancer patients

Head and Neck Cancer Research: 2023 study analyzed 24 cannabis extracts, with CBD-rich formulations showing efficacy in inducing cancer cell death, particularly when combined with CBC or THC in 2:1 ratios².

Squamous Cell Carcinoma Case Report: 2021 documented case of geriatric patient with SCC in situ treated with topical THC-rich oil, resulting in lesion regression with no recurrence after 14 months³.

Population Studies: 2009 study indicated 62% risk reduction in head and neck squamous cell carcinoma among long-term cannabis users (10-20 years) after adjusting for tobacco and alcohol use⁴.

Phase I Mesothelioma Trial: 2024 trial exploring safety and maximum tolerated dose of intra-pleural RSO-021 in mesothelioma patients, with doses of 90, 120, and 180 mg administered weekly.

Glioblastoma Research: Ongoing studies investigating cannabinoid combinations with conventional chemotherapy.

Symptom Management Trials: Multiple studies examining cannabinoids for pain, sleep, and quality of life in various cancer populations.

Case Report Analysis: 2022 comprehensive review of 77 case reports found that only 14% met criteria for strong evidence, with 81% providing insufficient data for therapeutic claims¹.

Preclinical vs. Clinical Gap: While laboratory studies show promising anti-tumor effects, translation to human efficacy remains unproven.

Methodological Issues: Most positive reports lack proper controls, concurrent treatments confound results, and publication bias favors positive outcomes.

Limited Follow-Up: Most studies focus on short-term effects with insufficient long-term safety data

High-Dose Protocols: Safety of intensive RSO protocols (1g/day) not established in controlled trials

Drug Interaction Studies: Limited clinical data on interactions with cancer treatments and other medications

Patient Profile

• Age: 67-year-old male
• Diagnosis: Stage IV pancreatic adenocarcinoma
• Presenting Issues: Severe pain (8/10), cachexia (15% weight loss), poor appetite, insomnia
• Previous Treatments: FOLFIRINOX chemotherapy, opioid pain management

RSO Treatment Protocol

• Initial Dose: 0.1ml twice daily (morning and evening)
• Titration: Increased by 0.1ml weekly based on tolerance
• Maximum Dose: 0.6ml three times daily (1.8ml total)
• Duration: 6 months with ongoing monitoring

Clinical Outcomes

Clinical Notes

This case demonstrates RSO's potential for symptom management in advanced cancer. The patient experienced significant quality of life improvements while maintaining conventional cancer treatment. Close monitoring was essential for managing side effects and drug interactions.

Patient Profile

• Age: 78-year-old female
• Diagnoses: Osteoarthritis, chronic insomnia, mild cognitive impairment
• Medications: Metformin, lisinopril, atorvastatin, zolpidem
• Presenting Issues: Joint pain, sleep disturbances, anxiety about cognitive decline

Conservative RSO Protocol

• Initial Dose: 0.025ml once daily (evening)
• Titration: Increased by 0.025ml weekly
• Optimal Dose: 0.1ml twice daily
• Special Considerations: Extra monitoring for cognitive effects

Clinical Outcomes

Clinical Notes

This case illustrates successful RSO use in elderly patients with careful dose titration and monitoring. The conservative approach prevented adverse effects while achieving therapeutic benefits. Regular cognitive assessments were crucial for safety monitoring.

Patient Profile

• Age: 34-year-old male veteran
• Diagnosis: PTSD, major depressive disorder, chronic pain
• Previous Treatments: Multiple antidepressants, antipsychotics, therapy
• Presenting Issues: Nightmares, hypervigilance, social isolation, chronic back pain

Targeted RSO Protocol

• Initial Dose: 0.1ml evening dose for sleep
• Daytime Addition: 0.05ml morning dose after 2 weeks
• Optimization: 0.2ml evening, 0.1ml morning
• Adjunct Therapy: Continued psychotherapy and reduced psychiatric medications

Clinical Outcomes

Clinical Notes

This case demonstrates RSO's potential in treatment-resistant PTSD when used as part of comprehensive care. The patient achieved significant symptom reduction while maintaining functionality. Integration with psychotherapy was essential for optimal outcomes.

Signs and Symptoms:

• Severe anxiety, panic, paranoia
• Disorientation, confusion
• Tachycardia, hypertension
• Nausea, vomiting
• Coordination problems

Immediate Management:

1. Reassurance and calm environment - Most symptoms resolve within 2-4 hours
2. Vital sign monitoring - Check BP, HR, respiratory rate
3. Supportive care - IV fluids if dehydrated, antiemetics if needed
4. Benzodiazepines - For severe anxiety (lorazepam 0.5-1mg)
5. Avoid antipsychotics - May worsen symptoms

Signs and Symptoms:

• Hallucinations (visual, auditory)
• Delusions, paranoid thoughts
• Disorganized thinking/speech
• Agitation, aggressive behavior

Immediate Management:

1. Safety assessment - Risk to self or others
2. Discontinue cannabis immediately
3. Psychiatric consultation - Emergency psychiatric evaluation
4. Antipsychotic medication - If severe (haloperidol, olanzapine)
5. Hospitalization - If safety concerns or severe symptoms

Signs and Symptoms:

• Chest pain, pressure
• Severe tachycardia (HR >120)
• Arrhythmias
• Syncope, near-syncope

Immediate Management:

1. Discontinue cannabis
2. 12-lead ECG - Assess for arrhythmias, ischemia
3. Cardiac enzymes - If chest pain present
4. Beta-blockers - For tachycardia (if no contraindications)
5. Cardiology consultation - If abnormal findings

Examples: California, Colorado, Washington, Oregon, Massachusetts

• Broad qualifying conditions including cancer, chronic pain, PTSD
• Licensed dispensaries with regulated products
• Home cultivation often permitted for patients
• Physician recommendations rather than prescriptions
• Patient registries with ID cards

Examples: Texas, Florida, Georgia, Utah

• Restricted qualifying conditions (epilepsy, cancer, terminal illness)
• Low-THC products only in some states
• Limited dispensary networks
• Strict physician requirements (registration, training)
• No home cultivation

Examples: Alabama, South Carolina, Wisconsin

• CBD products only (typically <0.3% THC)
• Very limited conditions (usually epilepsy)
• Research programs rather than full medical access
• University-based or hospital-only programs

Examples: Idaho, Kansas, Nebraska

• No legal medical cannabis access
• Criminal penalties for possession and use
• Federal hemp-derived CBD may be available
• Legislative efforts ongoing in some states

State Law Compliance

• ☐ Verify current state medical cannabis laws
• ☐ Confirm patient meets qualifying condition criteria
• ☐ Ensure physician registration/licensing current
• ☐ Review state-specific prescribing requirements
• ☐ Understand product restrictions and limitations

Institutional Policy Review

• ☐ Hospital/clinic cannabis policies
• ☐ Medical staff bylaws regarding cannabis
• ☐ Malpractice insurance coverage
• ☐ DEA registration implications
• ☐ Professional liability considerations

Documentation Requirements

• ☐ Detailed medical records supporting recommendation
• ☐ Informed consent documentation
• ☐ Alternative treatment considerations
• ☐ Risk-benefit analysis documentation
• ☐ Follow-up monitoring plans

Study: "The Effect of Cannabis Plant Extracts on Head and Neck Squamous Cell Carcinoma"

Key Findings: Analysis of 24 cannabis extracts revealed that CBD-rich formulations showed the most efficacy in inducing cancer cell death, especially when combined with CBC or THC in a 2:1 ratio - components present in RSO formulations.

Clinical Significance: This research provides the first systematic analysis of specific cannabinoid ratios for anti-cancer effects, supporting the therapeutic potential of full-spectrum extracts like RSO.

Source: Cancers Journal, 2023²

Study: Long-term cannabis use and head and neck cancer risk

Key Findings: 62% risk reduction in head and neck squamous cell carcinoma among users who consumed cannabis for 10-20 years, after adjusting for tobacco and alcohol use.

Clinical Significance: First large-scale epidemiological evidence suggesting potential cancer-preventive effects of long-term cannabis use.

Source: Cancer Prevention Research, 2009 (re-analyzed 2024)⁴

Study: Phase I trial of intra-pleural RSO-021 in mesothelioma patients

Key Findings: Safety data for doses of 90, 120, and 180 mg administered weekly, with preliminary efficacy signals.

Clinical Significance: First formal clinical trial specifically using RSO-type formulations in cancer treatment.

Source: ASCO Annual Meeting, 2024

Study: "Cannabis drug interactions: A comprehensive review"

Key Findings: Detailed analysis of CYP450 enzyme interactions, with specific focus on:

• CBD inhibition of CYP2C19 increasing clobazam levels
• THC/CBD inhibition of CYP3A4 affecting immunosuppressants
• Cannabis induction of CYP1A2 reducing theophylline and olanzapine levels

Clinical Significance: Provides evidence-based framework for managing drug interactions in clinical practice.

Source: CMAJ, 2024

Study: Machine learning approaches to optimize cannabinoid therapy

Key Findings: AI algorithms successfully identified optimal cannabinoid combinations and dosing schedules for individual patients based on genetic markers, medical history, and treatment response.

Clinical Significance: Represents the future of personalized cannabis medicine with precision dosing and formulation selection.

Source: Nature Digital Medicine, 2024⁵

A: Our RSO offers several key advantages over traditional homemade RSO:

• Safety: Lab-tested for purity, no solvent residue or contaminants
• Consistency: Precise cannabinoid concentrations for predictable effects
• Legal Compliance: Formulated to meet state regulations
• Customizable Potency: Decarboxylation option allows you to control THC levels
• Professional Quality: Pharmaceutical-grade production standards

A: Yes, but with important precautions:

• Start extremely low: Begin with 0.025ml (half the standard starting dose)
• Go very slow: Wait at least 2 hours before considering additional dosing
• Medical supervision: Consult with a healthcare provider familiar with cannabis medicine
• Safe environment: Use only in comfortable, safe settings with trusted support
• No driving: Never drive or operate machinery after use

A: Effects vary by administration method:

• Sublingual (under tongue): 15-45 minutes onset, 4-6 hours duration
• Oral ingestion: 45-120 minutes onset, 6-8 hours duration
• Factors affecting timing: Body weight, metabolism, food intake, tolerance
• Peak effects: Usually occur 1-3 hours after onset

A: If you experience uncomfortable effects:

• Stay calm: Effects are temporary and will pass
• Find a safe space: Comfortable, quiet environment with trusted support
• Hydrate: Drink water, avoid alcohol
• CBD may help: CBD can counteract some THC effects
• Seek medical help if: Severe anxiety, chest pain, or concerning symptoms
• Call 911 if: Difficulty breathing, severe panic, or safety concerns

A: Travel restrictions are complex and vary by location:

• Within Texas: Generally permitted for registered patients
• Interstate travel: Federal law prohibits crossing state lines
• Air travel: TSA follows federal law - not recommended
• International travel: Strictly prohibited, severe legal consequences
• Recommendation: Consult legal counsel for specific travel questions

A: Proper storage maintains potency and safety:

• Temperature: Cool, room temperature (60-70°F)
• Light: Dark location, away from direct sunlight
• Humidity: Dry environment, avoid bathroom storage
• Security: Locked container, away from children and pets
• Original packaging: Keep in original container with labels
• Shelf life: 12-18 months when stored properly

A: Yes, this product will likely cause positive drug tests:

• THC content: Contains both Delta-8 and Delta-9 THC
• Detection window: Can be detected for days to weeks
• Test types: Will show positive on urine, blood, and saliva tests
• Employment: May affect job opportunities or current employment
• Legal protection: Medical use may not protect against employment consequences
• Recommendation: Discuss with employer and legal counsel

A: Evidence varies by indication:

• Strong evidence: Chemotherapy-induced nausea, specific epilepsy syndromes (FDA-approved)
• Moderate evidence: Cancer-related pain, appetite stimulation, sleep disorders
• Limited evidence: Anti-cancer effects (preclinical only), neurodegenerative diseases
• Insufficient evidence: Most other claimed benefits lack clinical validation
• Recommendation: Use evidence-based approach, focus on symptom management

A: Comprehensive monitoring protocol includes:

• Initial assessment: Baseline labs, cognitive testing, cardiovascular evaluation
• Frequent follow-up: Weekly during initiation, monthly during optimization
• Efficacy measures: Validated scales for pain, mood, function, quality of life
• Safety monitoring: Side effects, drug interactions, cognitive function
• Laboratory monitoring: Liver function, drug levels for interacting medications
• Documentation: Detailed records of dose, effects, and clinical response

A: High-priority interactions requiring intensive monitoring:

• Warfarin: Increased bleeding risk, frequent INR monitoring required
• Clobazam: Significantly increased levels, dose reduction often needed
• Tacrolimus/Cyclosporine: Immunosuppressant toxicity risk
• Opioids: Respiratory depression risk, avoid combination if possible
• Theophylline: Reduced levels with chronic use, monitor therapeutic levels
• Chemotherapy: Unknown interactions, coordinate with oncology

A: Balanced approach considering patient autonomy and evidence:

• Honest discussion: Transparent about limitations of current evidence
• Risk-benefit analysis: Individual assessment of potential benefits vs. risks
• Alternative treatments: Ensure conventional options have been considered
• Informed consent: Detailed discussion of experimental nature
• Trial period: Time-limited trial with clear outcome measures
• Discontinuation criteria: Pre-established criteria for stopping treatment

A: Legal protections vary by state:

• State law compliance: Following state medical cannabis laws provides some protection
• Standard of care: Recommendations must meet same standards as other treatments
• Documentation: Thorough documentation essential for legal protection
• Professional guidelines: Following medical board guidance
• Malpractice insurance: Verify coverage for cannabis recommendations
• Legal consultation: Consider legal review of policies and procedures

A: Population-specific dosing considerations:

• Elderly patients: Start with 50% of standard dose, slower titration
• Cannabis-naive patients: Ultra-low starting doses, extensive education
• Pediatric patients: Specialized protocols, limited to specific conditions
• Patients with liver disease: Reduced doses, more frequent monitoring
• Psychiatric patients: Extra caution, close mental health monitoring
• Cancer patients: Coordinate with oncology, consider drug interactions

Quality of Life Impact

• RSO advantages: Multi-symptom relief, improved sleep, mood enhancement
• Conventional therapy: Often requires multiple medications for comprehensive symptom management
• Patient preference: Many patients prefer natural alternatives when effective

Healthcare Utilization

• Emergency visits: Potential reduction in ER visits for breakthrough symptoms
• Hospitalizations: May reduce admissions for pain, nausea, or appetite issues
• Specialist visits: Possible reduction in multiple specialist consultations

Long-Term Cost Considerations

• Addiction treatment: Lower risk compared to opioids
• Side effect management: Different side effect profile may reduce some costs
• Tolerance development: May be less problematic than with opioids

Consider RSO as First-Line When:

• Patient has multiple symptoms that could benefit from cannabis (pain, nausea, appetite, sleep)
• Conventional treatments have significant contraindications
• Patient strongly prefers natural/alternative approaches
• Legal medical cannabis program available
• Patient can afford out-of-pocket costs

Consider RSO as Second-Line When:

• Conventional treatments have failed or caused intolerable side effects
• Patient has developed tolerance to conventional medications
• Multiple medications needed for symptom control
• Quality of life significantly impacted despite conventional treatment

Avoid RSO When:

• Personal or family history of psychosis
• Severe cardiovascular disease
• Pregnancy or breastfeeding
• Legal restrictions in jurisdiction
• Patient unable to afford monitoring and follow-up
• Conventional treatments are highly effective and well-tolerated

📍 Address

810 Richmond Ave
Houston, TX 77006

Located in the vibrant Museum District, easily accessible from downtown Houston and surrounding areas.

📞 Phone

+1-832-416-2816

Speak directly with our knowledgeable staff about products, dosing, and medical cannabis questions.

📧 Email

[email protected]

For detailed inquiries, product information, and medical consultations.

🌐 Website

https://oilwellcbd.com

Complete product catalog, educational resources, and online ordering.

Weekdays

• Monday - Thursday: 10:00 AM - 7:00 PM

Weekend

• Friday - Saturday: 10:00 AM - 10:00 PM
• Sunday: 10:00 AM - 4:00 PM

Holiday hours may vary. Please call ahead during major holidays.

Benefits of In-Store Shopping:

• Personal consultation: One-on-one guidance from our trained staff
• Product examination: See and smell products before purchase
• Immediate availability: Take your products home the same day
• Educational support: Learn proper usage and dosing techniques
• Lab results review: Examine detailed test results and certificates

What to Bring:

• Valid government-issued ID (21+ required)
• Medical cannabis card (if applicable in Texas)
• List of current medications (for interaction screening)
• Medical records (if seeking medical consultation)
• Payment method (cash, debit, or credit card)

Online Ordering Process:

1. Visit our website: https://oilwellcbd.com
2. Browse products: Detailed product descriptions and lab results
3. Add to cart: Select quantity and any additional products
4. Checkout: Secure payment processing
5. Verification: Age and legal compliance verification
6. Pickup/Delivery: Schedule pickup or delivery (where available)

Online Benefits:

• 24/7 ordering convenience
• Detailed product information and reviews
• Order history and reorder functionality
• Special online promotions and discounts
• Discreet ordering process

Call 832-416-2816 to place orders over the phone with our knowledgeable staff.

Phone Ordering Benefits:

• Personal consultation during ordering
• Immediate answers to product questions
• Customized recommendations based on needs
• Assistance with dosing and usage guidance
• Scheduling of pickup or delivery